|
ZNF773 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.176700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.758500E-03 |
| Normal-vs-Stage2 |
3.008400E-02 |
| Normal-vs-Stage3 |
1.594180E-02 |
| Normal-vs-Stage4 |
2.47229999994492E-06 |
| Stage1-vs-Stage2 |
4.205800E-01 |
| Stage1-vs-Stage3 |
4.226000E-01 |
| Stage1-vs-Stage4 |
1.239630E-02 |
| Stage2-vs-Stage3 |
9.296200E-01 |
| Stage2-vs-Stage4 |
8.872200E-02 |
| Stage3-vs-Stage4 |
6.341700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.256910E-03 |
| Normal-vs-AfricanAmerican |
1.388220E-01 |
| Normal-vs-Asian |
1.930470E-02 |
| Caucasian-vs-AfricanAmerican |
1.920590E-01 |
| Caucasian-vs-Asian |
5.499000E-01 |
| AfricanAmerican-vs-Asian |
3.360400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.585400E-04 |
| Normal-vs-Female |
3.987400E-01 |
| Male-vs-Female |
1.631900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.374100E-02 |
| Normal-vs-Extreme_Weight |
1.384990E-03 |
| Normal-vs-Obese |
8.020400E-02 |
| Normal-vs-Extreme_Obese |
2.596000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.403800E-01 |
| Normal_Weight-vs-Obese |
7.345600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.173800E-01 |
| Extreme_Weight-vs-Obese |
2.074400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.139400E-01 |
| Obese-vs-Extreme_Obese |
4.783800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.384400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.530200E-02 |
| Normal-vs-Age(61-80Yrs) |
5.775700E-04 |
| Normal-vs-Age(81-100Yrs) |
4.422700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.774000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.841550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.044800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.071640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.821610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.964600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.556600E-03 |
| Normal-VS-Type2 PRCC |
1.52549999998808E-06 |
| Normal-VS-KIRP CIMP |
8.546200E-01 |
| Normal-VS-Unclassified PRCC |
2.387600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.010800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.016600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.825600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.046500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.295390E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.011600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.93281999999462E-05 |
| Normal-vs-N1 |
1.938810E-01 |
| Normal-vs-N2 |
2.698100E-03 |
| N0-vs-N1 |
2.714600E-01 |
| N0-vs-N2 |
3.122600E-01 |
| N1-vs-N2 |
3.127800E-01 |
|
|
